Taken together, not only α-GalCer but, importantly, OCH administration induced more inflammatory cells to liver, including activating CD4+ and CD8+ T, NK, and B cells, which led to portal inflammation and liver fibrosis. This evidence concerns the gene CD8A and Hepatic fibrosis.